Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2025)

Rockwell Medical's Depreciation and Depletion history spans 9 years, with the latest figure at $400000.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion changed 0.0% year-over-year to $400000.0; the TTM value through Dec 2025 reached $1.6 million, changed 0.0%, while the annual FY2025 figure was $1.6 million, 0.0% changed from the prior year.
  • Depreciation and Depletion reached $400000.0 in Q4 2025 per RMTI's latest filing, roughly flat from $400000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q3 2023 to a low of $100000.0 in Q3 2021.
  • Average Depreciation and Depletion over 5 years is $278400.0, with a median of $300000.0 recorded in 2021.
  • Peak YoY movement for Depreciation and Depletion: tumbled 50.0% in 2021, then surged 300.0% in 2023.
  • A 5-year view of Depreciation and Depletion shows it stood at $168000.0 in 2021, then grew by 19.05% to $200000.0 in 2022, then skyrocketed by 100.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Depreciation and Depletion are $400000.0 (Q4 2025), $400000.0 (Q3 2025), and $400000.0 (Q2 2025).